Peytant
1 known investors
Peytant develops amnion-derived membrane coverings using human placental tissue to reduce the body's foreign body response in implants used for luminal disease treatment. The company's products are designed to increase patency and help clinicians manage vascular and other luminal conditions.
BiotechDeep TechMedical Devices
Founders & leadership
JS
John SchorglFounder & Executive Chairman
SH
Steve HealyFounder & Director
Investors · 1
In the news
- Plymouth Startup Is Reinventing the Stent with Human Tissue | Twin Cities Businesstcbmag.com · 2026
- Peytant Solutions - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Regenerative Medicine Startup Peytant Solutions, Inc. “Graduates” From University Enterprise Laboratories, Receives $100k Biobusiness Grant And Pursues Additional Funding - BioSpacebiospace.com · 2017
- Which MN Health Care Startups Landed The Most Angel Funding In 2016? | Twin Cities Businesstcbmag.com · 2017